PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
Clinical trial NCT02104427 · COMPLETED
Trial details
- NCT number
- NCT02104427
- Sponsor
- GPCR Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2015-11-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.